OQROGet OQRO Pro
Politician trade (Senate)

Edwards Lifesciences (EW)Sen. Alan Armstrong disclosed a purchase $1K–$15K

Sen. Alan Armstrong disclosed a purchase of Edwards Lifesciences in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
116 days
Disclosure lag
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
  2. Feb 12, 2026Insider · 1 personInsiders: 2 sales (~$1.7M)
  3. Feb 24, 2026FDAFDA device clearance: HemoSphere Nano Monitor (HSNANO1)
  4. Feb 25, 2026InsiderOfficer sold ~$2.01M of EW shares in the open market
  5. Mar 2, 2026InsiderOfficer sold ~$974K of EW shares in the open market
  6. Mar 11, 2026Insider · 2 peopleInsiders: 3 sales (~$1.2M)
  7. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  8. Mar 27, 2026 · this disclosureCongressDisclosed purchase of EW — reported range $1,001 - $15,000

What came next

  1. Mar 27, 2026FDARecall: Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO
  2. Apr 2, 2026Insider · 1 personInsiders: 2 sales (~$1.8M)
  3. Apr 6, 2026InsiderOfficer sold ~$83K of EW shares in the open market
  4. Apr 9, 2026Insider · 1 personInsiders: 2 sales (~$1.0M)
  5. Apr 17, 2026FDAFDA device clearance: Edwards eSheath+ introducer set
  6. Apr 23, 2026Company filing · Form 8-K · ResultsReported its results
  7. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  8. May 1, 2026Insider · 1 personInsiders: 2 sales (~$85K)
  9. May 2, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 4, 2026, Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), announced that Theodora Mistras has been appointed as the Corporate Vice President, Chief Financial Officer of the Company, effective May 29, 2026, to succeed Scott B. Ullem in that position.”
  10. May 4, 2026InsiderOfficer sold ~$86K of EW shares in the open market
  11. May 7, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“of Certain Officers Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program At the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Edwards Lifesciences Corporation, a Delaware Corporation (the “Company”), the Company’s stockholders approved the amendment and restatement of the Company’s Long-Term Stock Incentive Compensation Program (the “Long-Term Stock Program”).”
  12. May 11, 2026InsiderOfficer sold ~$47K of EW shares in the open market
  13. May 12, 2026Insider · 1 personInsiders: 2 sales (~$2.8M)
  14. May 15, 2026Insider · 1 personInsiders: 2 sales (~$1.5M)
  15. May 18, 2026InsiderOfficer sold ~$50K of EW shares in the open market
  16. May 22, 2026InsiderOfficer sold ~$127K of EW shares in the open market
  17. May 27, 2026InsiderOfficer sold ~$2M of EW shares in the open market
  18. May 29, 2026InsiderOfficer sold ~$49K of EW shares in the open market
  19. Jun 5, 2026FDAFDA device clearance: Fogarty Spring Clips, Handleless Clamps, and Clamp Inserts
  20. Jun 11, 2026FDAFDA device clearance: Respiration Rate algorithm
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 11 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 21 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

Other disclosures at Edwards Lifesciences

Everything OQRO holds on this company is on its EW page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data